Surgical aortic valve replacement (SAVR) has long been the standard treatment for severe
symptomatic aortic stenosis (AS). However, transcatheter aortic valve replacement (TAVR) …

OBJECTIVES The concept of non-inferiority is widely adopted in randomized trials
comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve …

Background In the era of transcatheter aortic valve implantation, this study was conducted to
investigate the current trend of aortic valve procedures in Korea and to evaluate the early …

Background Surgical treatment of asymptomatic severe aortic stenosis (AS) has been
gaining attention ever since the results of the Early Surgery Versus Conventional Treatment …

Objective Recent approval of transcatheter aortic valve replacement (TAVR) in patients at
low surgical risk has resulted in a rapid real-world expansion of TAVR in patients not …

We reviewed the cardiac surgical literature for 2023. PubMed displayed almost 34,000 hits
for the search term “cardiac surgery AND 2023.” We used a PRISMA approach for a results …

The current paradigm for the management of patients with aortic stenosis (AS) incorporates
a growing trend toward referral for surgery at progressively earlier stages in its natural …

Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic
stenosis, with its use now approved for patients in all risk groups. 1 The minimally invasive …

Objective To examine long-term surgical aortic valve replacement (SAVR) outcomes for
young (ie, younger than age 65 years) patients with bicuspid aortic valve and aortic stenosis …

Risk assessment has come to be regarded as an essential element in the practice of
cardiothoracic surgery. This has become even more critical in the current era when patients …